GB Patent

GB1226394A

Expires 1971-03-24 · 55y expired

What this patent protects

1,226,394. Iron - glycerin - hydroxycarboxylic acid complexes. PHARMAZEUTISCHE FABRIK MONTAVIT G.m.b.H. 3 July, 1968 [4 July, 1967], No. 31693/68. Heading C2C. Iron (III) - glycerin - hydroxycarboxylic acid complexes are prepared by mixing in an aqueous medium an iron (III) compo…

USPTO Abstract

1,226,394. Iron - glycerin - hydroxycarboxylic acid complexes. PHARMAZEUTISCHE FABRIK MONTAVIT G.m.b.H. 3 July, 1968 [4 July, 1967], No. 31693/68. Heading C2C. Iron (III) - glycerin - hydroxycarboxylic acid complexes are prepared by mixing in an aqueous medium an iron (III) compound, glycerin and a hydroxycarboxylic acid, and adjusting the pH of the reaction mixture to a value of at least 5. Preferably the pH of the reaction mixture is 5-8 and the mol. ratios of the iron (III) compound: glycerin: hydroxycarboxylic acid are 1: ¢- 10:1/3-3. The iron (III) compound may be ferric chloride, ferric sulphate or an iron (III) hydroxycarboxylic acid salt such as ferric citrate. The hydroxycarboxylic acid reactant may be tartaric acid, citric acid, malic acid or gluconic acid, either in its free form or in the form of a ferric salt. The complexes may be modified by mixing the reactants and adjusting the pH to 5-6 and then adding natural or depolymerized inulin to the reaction mixture and readjusting the pH to a value of 7 to 8 to give an inulin modified complex. Pharmaceutical compositions contain the above novel iron (III) complexes in aqueous solution with an iron content of 5-100 mg./ml. of solution. The solution may contain a resorption retarding agent such as polyvinyl pyrrolidone. The solutions may be produced in ampoules for parenteral administration.

Drugs covered by this patent

Patent Metadata

Patent number
GB1226394A
Jurisdiction
GB
Classification
Expires
1971-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.